Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study

Brain Behav Immun. 2021 May:94:41-50. doi: 10.1016/j.bbi.2021.03.008. Epub 2021 Mar 11.

Abstract

Vaccine hesitancy could undermine efforts to control COVID-19. We investigated the prevalence of COVID-19 vaccine hesitancy in the UK and identified vaccine hesitant subgroups. The 'Understanding Society' COVID-19 survey asked participants (n = 12,035) their likelihood of vaccine uptake and reason for hesitancy. Cross-sectional analysis assessed vaccine hesitancy prevalence and logistic regression calculated odds ratios. Overall vaccine hesitancy was low (18% unlikely/very unlikely). Vaccine hesitancy was higher in women (21.0% vs 14.7%), younger age groups (26.5% in 16-24 year olds vs 4.5% in 75 + ) and those with lower education levels (18.6% no qualifications vs 13.2% degree qualified). Vaccine hesitancy was high in Black (71.8%) and Pakistani/Bangladeshi (42.3%) ethnic groups. Odds ratios for vaccine hesitancy were 13.42 (95% CI:6.86, 26.24) in Black and 2.54 (95% CI:1.19, 5.44) in Pakistani/Bangladeshi groups (compared to White British/Irish) and 3.54 (95% CI:2.06, 6.09) for people with no qualifications versus degree. Urgent action to address hesitancy is needed for some but not all ethnic minority groups.

Keywords: COVID-19; Ethnicity; Inequalities; Socioeconomic position; Vaccine hesitancy; Vaccine uptake.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Cross-Sectional Studies
  • Ethnicity
  • Female
  • Humans
  • Longitudinal Studies
  • Minority Groups
  • SARS-CoV-2
  • United Kingdom
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • Vaccines